Development of antibacterial agents of the nalidixic acid type.
D000818:Animals; D000900:Anti-Bacterial Agents; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D002626:Chemistry, Pharmaceutical; D004353:Drug Evaluation, Preclinical; D006801:Humans; D009268:Nalidixic Acid / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology; D012107:Research Design; D013329:Structure-Activity Relationship; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D009268:Nalidixic Acid